2023 US Health Services
Financial Strength Rankings using Artificial Intelligence
Top rated | 22 of 91 |
Best rating | 309 % |
Worst rating | -2,295 % |
New companies | 4 |
Negative Economic Capital Ratio | 28 of 91 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 22 of 91 |
Best rating | 309 % |
Worst rating | -2,295 % |
New companies | 4 |
Negative Economic Capital Ratio | 28 of 91 |
BioRestorative Therapies Inc. climbed 32 positions from 89 to 57 due to its excellent Assets, Current.Teladoc Health Inc. lost 84 positions from 4 to 88 due to its bad Goodwill Impairment Loss.ENZO BIOCHEM INC entered the 2023 ranking at rank 39, making it the best newcomer.
Revenues | 205 B |
Assets | 254 B |
Expenses | 212 B |
Stockholders Equity | 126 B |
Unprofitable Companies | 56 of 91 |
We’re thrilled to have participated in the TDWI [https://www.linkedin.com/company/tdwi/] Roundtable held on April [...]
Photo source: https://openai.com/dall-e-3/ RealRate is excited to announce that the new 2024 [...]
We are extremely excited to announce that an interview with Holger Bartel has [...]
On February 14th, 2024, something momentous happened. Nvidia, the chip and graphics card [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Pharma are [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Savings are [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2023 ranking for U.S. Chemicals are [...]
Source: https://openai.com/dall-e-3/ The machines have emerged and the results for RealRate’s 2023 [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai